Success Story: No Delays, No RFE: A Chinese Senior Scientist Secure EB1A Approval Swiftly
Client’s Testimonial:
“Chen Immigration has done a tremendous job in preparing my case. The entire process was smooth and straightforward, with documents and suggestions provided promptly. Having had negative experiences with other immigration law firms, I truly appreciate the professionalism and expertise of Chen Immigration. Their critical insights and guidance are invaluable in navigating the complexities of the immigration process. If you want to maximize your chances of success, working with a diligent and experienced firm like Chen Immigration is essential.”
On April 9th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the Field of Chemical Biology (Approval Notice).
General Field: Chemical Biology
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: April 9th, 2025
Processing Time: 14 months, 8 days
Case Summary:
At North America Immigration Law Group, we are proud to celebrate another remarkable success story of a client whose exceptional research in chemical biology has been recognized through the approval of an EB1A (Alien of Extraordinary Ability) petition. The case was approved swiftly without any RFE issues, affirming our client’s extraordinary impact in advancing fundamental biochemical research with broad medical and technological applications.
Client Background and Field
Our client holds a Ph.D. in chemistry and is an accomplished scientist in chemical biology, specializing in proteomics and protein modifications. The client’s pioneering work focuses on uncovering the complex mechanisms that regulate protein modifications - a process essential for fundamental cellular functions and human health. Through innovative chemical and biological methodologies, the client’s research has opened new pathways for understanding disease mechanisms and developing targeted therapeutic strategies.
The client’s most distinguished contribution includes the creation of a comprehensive reference of thousands of protein modification sites regulated by key enzymes, which has become a cornerstone for subsequent studies worldwide. Currently, the client continues to work in the United States, conducting advanced research in the same field, contributing to breakthroughs in drug discovery and molecular biology.
Petition Strategy and Highlights
To establish the client’s qualifications at the highest level of scientific achievement, we presented:
- 17 peer-reviewed journal articles (including 6 first-authored or co-first-authored) and 1 book chapter, published in some of the most selective journals.
- 904 total citations, according to Google Scholar, reflecting the wide-reaching impact of the client’s work.
- 24 instances of peer review service for major international journals.
- Evidence of significant research funding from top organizations such as the National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS), National Science Foundation (NSF), and the Welch Foundation, all of which support transformative scientific research.
Our petition demonstrated that the client’s scientific discoveries have directly influenced the work of leading researchers worldwide. The client’s methods and findings have been adopted in laboratories across the United States and abroad to investigate cancer biology, cellular metabolism, and drug development. This global recognition confirmed that the client’s contributions represent major significance to the advancement of chemical biology.
To strengthen the case, we submitted four expert recommendation letters from internationally recognized scientists in the field.
“Taken together, these citations illustrate the applicability of [Client’s] research to the concurrent works of his peers. To end his career at this stage would deal the field of chemical biology a palpable blow.”
Case OutcomeDespite the rigorous scrutiny associated with EB1A adjudications, the client’s petition was approved based on our carefully structured arguments and extensive supporting evidence. The approval serves as a clear acknowledgment of the client’s extraordinary ability and international recognition.
We are honored to have represented this remarkable scientist and to have played a role in facilitating continued contributions to the United States’ leadership in biomedical innovation. The client’s ongoing research in chemical proteomics and protein modifications will continue to drive forward discoveries in disease treatment and human health for years to come.